Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists.
Yamazaki T, Hannani D, Poirier-Colame V, Ladoire S, Locher C, Sistigu A, Prada N, Adjemian S, Catani JP, Freudenberg M, Galanos C, André F, Kroemer G, Zitvogel L.
Yamazaki T, et al. Among authors: kroemer g.
Cell Death Differ. 2014 Jan;21(1):69-78. doi: 10.1038/cdd.2013.72. Epub 2013 Jun 28.
Cell Death Differ. 2014.
PMID: 23811849
Free PMC article.